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1. Introduction 
With the recent development of biospecific 
adsorbants, progress has been made towards the 
purification of steroid receptors [l-5] . Standard 
biochemical techniques presently used to characterize 
steroid receptors could be complemented with an 
immunological approach if antibodies were available. 
Although the production of antiserum has been 
attempted [6], unequivocal evidence for antibodies 
against the receptor has not yet been presented. 
The purpose of the present study was to determine 
if the estrogen receptor from calf uterine cytosol was 
immunogenic in rabbits, a study which consequently 
required the development of a method to test anti- 
sera for anti-receptor antibodies. The identification of 
receptor-antibody interactions was complicated by 
2 problems: (1) the receptor available for testing 
antisera was present at concentrations less than 10 nM 
in partially purified preparations and (2) it was 
necessary to detect antibodies complexes with an 
antigen which can only be identified by its saturable, 
non-covalent and specific binding of a tritiated 
steroid. The separation of [3H]estradiol receptor 
from antibody-associated [3H]estradiol receptor and 
free [jH]estradiol by gel filtration on acrylamide- 
agarose columns provided a means to solve these 
problems. 
This preliminary report describes the production 
of antisera using pg quantities of partially purified 
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estrogen receptor and a chromatographic method for 
detecting small amounts of soluble antibody-receptor 
complexes. 
2. Materials and methods 
2.1. Preparation of aggregated and ‘4s Trypsin’ 
non-aggregated forms of estrogen receptor 
(flow sheet in fig.1). 
Cytosol was prepared from frozen calf uteri as 
previously described [3,4]. The estrogen receptor 
was partially purified by precipitation at 4°C with 
either ammonium sulfate (30% saturation for 1 h) 
or sodium citrate (0.55 M for 2 h). Following centri- 
fugation at 35 OOOg for 10 min, the pellets were 
suspended in TE buffer (50 mM Tris-HCl, 1.5 mM 
EDTA, pH 7.4) equal to 10% of the initial cytosol 
volume and treated with trypsin (Calbiochem, 
1 X crystallized; 100 mg/ml cytosol for 3-10 h 
at 4°C). Under these conditions, one can distinguish 
in these preparations 2 molecular forms of receptor. 
One is the so-called ‘4s Trypsin’ form of the 
receptor [7] which has very little tendency to 
aggregate. The other form sediments with S values 
greater than 1 OS and is operationally defined as 
aggregated receptor. The trypsin-treated solution 
was then centrifuged (35 OOOg, 10 min.), and pellets 
containing the aggregated receptor derived from 
sodium citrate precipitation (designated AGR-1) 
were used to immunize rabbits. 
Supernatants, containing aggregated and ‘4s 
Trypsin’ receptor molecules, were chromatographed 
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Fig.1. Flowsheet for the preparation of aggregated and ‘4s Trypsin’ forms of the estrogen receptor. 
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on a Sephadex G-200 column (300-900 ml were 
filtered on a 16 liter column). Fractions constituting 
the peak of aggregated receptor activity were pooled 
and precipitated with ammonium sulfate (45% 
saturation, 12 h, 4°C). This aggregate-containing 
precipitate (AGR-2) was also used for immunizations. 
After pooling the fractions forming the 4s peak 
activity and precipitating with ammonium sulfate 
(45% saturation), the pellet containing the ‘4s Trypsin’ 
receptor was dissolved in TE buffer (final volume 
was 10% of the pooled fractions volume) and used 
either for immunization or to test antisera as 
described below. 
(AGR-1). Trial bleedings were made between the 
2 boosters and 16 days after the last injection. 
Rabbit R-2 received 25 c(g aggregated receptor 
AGR-2 emulsified in Freund’s Complete Adjuvant 
at 8 intradermal, 2 subscapular and 2 intramuscular 
(thigh) sites. Boosters were given, using Incomplete 
Adjuvant, after 5 weeks (50 pg receptor as AGR-2), 
followed 4 days later with an identical injection and 
12 weeks later with 150 pg receptor as AGR-1. Trial 
bleedings were made between the second and third 
boosters and 17 days after the last injection. 
Receptor activity was monitored throughout the 
purification procedure by measuring the specific 
binding of [3H]estradiol using 2 differential dissocia- 
tion methods. The techniques involved (1) removal of 
free and non-specifically bound [3H]estradiol with 
dextran-coated charcoal [8] and (2) binding of the 
[jH]estradiol receptor complex on hydroxyapatite 
columns [9]. Radioactivity ([3H]estradiol 48-55 
Ci/mmole, CEA) was counted at 30% efficiency in 
Bray’s scintillation solution. 
Antisera were also prepared against cytosol 
preparations which had been exposed to a biospecific 
adsorbant to remove estrogen receptors, as pre- 
viously described [4]. Rabbits were injected sub- 
cutaneously with cytosol preparations containing 
less than 5 ng receptor/ml (CSR) emulsified in 
Freund’s Complete Adjuvant for the first injection 
and in Incomplete Adjuvant for booster injections. 
Sheep anti-rabbit globulins were purchased from 
GIBCO. 
All antisera were stored at -20°C without 
preservatives. 
2.2. Production of antisera 2.3. Detection of antibodies against the estrogen 
Adult male rabbits (new Zealand White and Fauve 
Bourgogne breeds) were immunized with non- 
aggregated and/or aggregated receptor preparations. 
Blood containing pre-immune sera was collected 
from marginal ear veins; animals were deprived of 
food for 16-20 h before bleedings were made. Seven 
rabbits were injected using various immunization 
schedules. The 2 antisera chosen to run the complete 
series of controls were produced in rabbits R-l and 
R-2; these 2 immunization schedules are described 
below. 
receptor 
Before rabbit sera were used in these experiments, 
they were centrifuged at 12 000 g for 30 min (4” C) 
Rabbit R-l (Fauve Bourgogne breed) was injected 
with 70 mg protein containing 20 pg ‘4s Trypsin’ 
receptor (in 0.75 ml phosphate buffered saline, 
pH 7.4) emulsified with 1.5 ml Freund’s Complete 
Adjuvant (DIFCO) at 15 intradermal (back) and 
2 subscapular sites. Two booster injections were 
made at intradermal, intramuscular and subscapular 
sites using Freund’s Incomplete Adjuvant 9 weeks after 
the initial injection using 3 ml of a ‘4s Trypsin’ 
receptor preparation containing 60 pg of ‘4s Trypsin’ 
receptor and a total of 45 mg protein and 7 weeks 
later using 150 ,ug receptor in aggregated form 
The following components were incubated in 
sterile plastic tubes at 4°C with constant agitation for 
24 or 48 h: (1) Rabbit antisera or control sera 
(15-20 ~1 with a total of 1 .1-l .5 mg protein, (2) 
100 ~1 of a preparation containing 7-20 ng of 
partially purified [3H]estradiol ‘4s Trypsin: receptor 
(These amounts were calculated on the basis of a 
mol. wt. of 60 000 and assuming one steroid binding 
site per molecule of receptor), (3) sufficient TE 
buffer to bring the total incubation volume to 120 ~1. 
Samples (100 ~1) of the incubation milieu were 
filtered on ACA-34 gel (LKB) columns (0.8 X 22 cm) 
containing a 0.5 cm layer of Sephadex G25 (coarse) 
at the bottom. TE buffer was used as the equilibrating 
and working buffer. The flow rate was 2-4.5 ml/h; 
0.22 ml fractions were collected. After fractions were 
transferred into scintillation vials, the tubes were 
rinsed with 2 aliquots (5 ml each) of scintillation 
liquid (4 g omnifluor, 11 toluene, 0.31 ethanol) 
which were added to the vials to insure that total 
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Fig.2. Gel filtration of [‘Hlestradio! receptor complexes on ultrogel ACA-34. Procedural details are described in Materials and 
methods; each point on the graph represents the total radioactivity in one fraction (200 ~1). (A) chromatography of 100 pl(7 ng) 
of a preparation of partially purified, ‘4s Trypsin’ receptor incubated with [3H]estradiol. (B) chromatography of [3H]estradiol 
receptor complex incubated for 48 h at 4°C with anti-receptor antiserum R-l (A-A-A) or pre-immune R-l serum (a-a-a). (C) 
Chromatography of hormone receptor complexes (using f3H]estradiol diluted with non-radioactive hormones) incubated for 24 h 
at 4°C with anti-receptor antiserum R-2. Prior to exposure to antiserum, the receptor preparation was incubated with [ ‘Hlestradiol 
isotopically diluted with non-radioactive stradiol (o-o-o) or non-radioactive androstanolone (o-o-o). 
fraction radioactivity was counted (no counts were 
observed in a third rinse volume of scintillation liquid). 
Counting efficiency was 28-30%; results were 
expressed as dpm which were calculated from the 
cpm using an external standard. 
2.4. Protein measurements 
The proteins were measured according to the 
technique of Lowry et al. [lo]. 
3. Results 
Fig.2A shows the effluent profile of the ‘4s 
Trypsin’ estrogen receptor bound to [3H] estradiol. 
The three different ‘4s Trypsin’ receptor preparations 
used to test antisera gave similar results. 
Incubation of the [3H]estradiol receptor complex 
with antiserum RI effected the displacement of 21% 
of the macromolecular bound dpm from the 4s 
peak into the void volume (fig.2B). Similar results 
were obtained with 5 other antisera. After incubation 
of the [3H]estradiol receptor complex with pre- 
immune serum, 5% of the bound radioactivity was 
observed in the void volume. 
There was little or no bound radioactivity in the 
void volume or ‘4s’ peak when the receptor was 
incubated with [3H]estradiol plus a 103-fold excess 
of non-radioactive estradiol before the steroid 
receptor complex was exposed to antisera. A similar 
isotopic dilution with non radioactive androstanolone 
(Sa-androstane-17/I-ol-3-one) did not interfere with 
the shift in dpm (fig.2C). 
Little void volume radioactivity (3% of the 
macromolecular-bound dpm) was detected when [3H] 
estradiol receptor complex was treated with antisera 
against non-receptor cytosol proteins (fig.3). A 
similarly small percentage of bound dpm was dis- 
placed when the [jH]estradiol complex was incubated 
with sheep anti-rabbit globulins and preimmune rabbit 
74 
Volume 63, number 1 FEBS LETTERS March 1976 
Fig.3. Chromatography of [aH]estradiol‘4S Trypsin’ receptor 
complex incubated for 24 h at 4°C with anti-receptor anti- 
serum (e-o-o), with anti-serum against non-receptor cytosol 
antigens (A-a-A) or with pre-immune serum R-2 plus sheep 
anti-rabbit globulins (o-o-o). 
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serum (fig.3). Precipitin reactions were observed in 
agarose double diffusion plaques [ 111 between anti- 
receptor antisera and antigens in the preparations con- 
taining ‘4s Trypsin’ receptor and between sheep anti- 
rabbit globulins and pre-immune rabbit serum. 
Table 1 summarizes results showing the distribu- 
tion of radioactivity after gel filtration of [3H] 
estradiol labeled ‘4s Trypsin’ receptor preparations 
incubated with various sera. 
Table 1 
Distribution of bound radioactivity after gel filtration of [3H]estradiol receptor 
complexes incubated with various sera 
Reagents incubated with 
[aH]estradiol receptor 
mg serum 
protein 
Incubation 
time (h) 
Macromolecular 
bound d.p.m. 
% bound d.p.m. 
in void volume 
Tris-HCI EDTA buffer 
Anti R-la 
Pre-immune R-la 
Anti R-l ([‘HI estradiol diluted with 
non-radioactive stradiol)u 
Anti R-l ([jH]estradiol dilutedbwith 
non-radioactive androstanolone 
Anti R-2a 
Anti CSRC 
Pre-immune R-2a+ 
sheep anti-rabbit globulin 
_ 48 
1.4 48 
1.5 48 
1.4 48 
1.4 48 
1.1 24 
1.1 24 
1.5 24 
15,172d 6% 
26,025e 21% 
‘24,912e 5% 
3,43 1e 
23.31ge 20% 
39,44gf 22% 
35,020f 4% 
32,15gf 3% 
Procedural details for receptor-sera incubation and gel filtration of complexes were described in 
Materials and methods. Bound radioactivity was calculated by summing the dpm present in the first 11 ml 
of effluent. 
a Sera obtained from rabbits R-l (bled 16 days after the second booster) and R-2 (bled 17 days after third 
booster) immunized with receptor preparations. 
bTo detect saturable binding of estradiol, the receptor was incubated, prior to exposure to antiserum, with 
[ ‘Hlestradiol isotopically diluted with non-radioactive stradiol (E,) or non-radioactive androstanolone. 
‘Antiserum produced in rabbit CSR against cytosol preparations treated with the biospecific adsorbant o 
remove receptor. 
dTeTf Three different partially purified preparations of ‘4s Trypsin’ receptor containing 7,14 and 20 ng 
receptor/100 ~1, respectively. 
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4. Discussion 
The displacement of 20-22% of the bound 
radioactivity from the ‘4s’ peak into the void volume 
after incubation of [3H]estradiol receptor with anti- 
serum was interpreted as representing the formation 
of antibody-receptor complexes. The presence of 
dpm in the void volume was due to the displacement 
of a macromolecule which is probably the ‘4s 
Trypsin’ receptor as judged by its elution volume on 
an Ultrogel column, and its high affinity, specific and 
saturable binding of estradiol. In addition, the 
manner in which the antigens were prepared, and the 
inability of androstanolone to compete for the 
estradiol binding site make it highly unlikely that 
antibodies have been raised against a contaminant 
such as an oestradiol binding plasma protein. Results 
obtained after incubation of the receptor with pre- 
immune sera, antiserum against non-receptor cytosol 
antigens (CSR) or a combination of pre-immune 
serum and sheep anti-rabbit globulins indicated that 
most of the displaced radioactivity effected by 
anti-receptor sera was due to antibody-receptor 
interaction. 
The total amount of bound dpm (void volume plus 
‘4s’ peak radioactivity) recovered after exposure of 
the [jH]estradiol receptor to antisera was equal to 
or greater than the total bound dpm recovered when 
the [3H]estradiol receptor was exposed to pre- 
immune serum or other antisera (not produced against 
receptor preparations). These results suggested that, 
under the conditions used in this study, the antibody- 
receptor complex did not precipitate, but remained 
soluble. Precipitation of the complex would require 
a second step to separate antibody-bound receptor 
from free receptor. Methods such as the double anti- 
body technique were considered to risk perturbing 
the interaction between receptor and its steroid and 
to increase the probability of non-specific aggregation 
or trapping of the [3H]estradiol receptor. Filtration 
on Ultrogel columns avoided the potential problems 
of classical precipitation methods and permitted the 
detection of small amounts of soluble antibody- 
receptor complexes. 
Thus, these results show that multispecific antisera 
(forming precipitin bands with cytosol antigens in 
76 
double diffusion in gel tests) which were produced in 
rabbits immunized with partially purified ‘4s Trypsin’ 
receptor plus aggreated receptor (rabbit R-l) or with 
aggregated receptor only (rabbit R-2) reacted with the 
‘4s Trypsin’ receptor. Work is in progress to render the 
antisera specific for the estrogen receptor, which should 
provide an important tool for characterizing these 
proteins. 
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